Cargando…
Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53
BACKGROUND: This study was performed to explore the role of Re in liver IRI progression. Hypoxia and reperfusion (H/R) treated human embryo liver cell line (L-02) was used to establish a liver IRI model. MATERIALS AND METHODS: Cell behaviors were detected using CCK-8, flow cytometry and TUNEL staini...
Autores principales: | Ding, Weixing, Peng, Huijuan, Tian, Jianyou, Wang, Siyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560062/ https://www.ncbi.nlm.nih.gov/pubmed/37809663 http://dx.doi.org/10.1016/j.heliyon.2023.e20285 |
Ejemplares similares
-
METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes
por: Song, Huiwen, et al.
Publicado: (2019) -
METTL3-Mediated m(6)A RNA Modification Regulates Corneal Injury Repair
por: Dai, Yarong, et al.
Publicado: (2021) -
Delta Opioid Peptide Targets Brain Microvascular Endothelial Cells Reducing Apoptosis to Relieve Hypoxia-Ischemic/Reperfusion Injury
por: Zhang, Ran, et al.
Publicado: (2022) -
A case of precipitate in intravenous line when general anesthesia implemented with remimazolam
por: Liu, Yingge, et al.
Publicado: (2022) -
Remimazolam use for awake craniotomy
por: Tachibana, Shunsuke, et al.
Publicado: (2021)